Ftse Mib
33.746,66
-1,60%
DAX
17.932,17
-1,10%
S&P 500
5.018,39
-0,34%
NASDAQ Composite
15.605,48
-0,33%
Bitcoin
58.275,70
0,07%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ AN2 Therapeutics Inc (ANTX) AN2 Therapeutics Inc (ANTX) Notizie

AN2 Therapeutics Inc

ANTX
2,39
-0,01 (-0,42%)
02 Mag 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
28/3/202421:10BWAN2 Therapeutics Reports Fourth Quarter and Full Year 2023..
13/2/202423:11EDGAR2Form SC 13G - Statement of acquisition of beneficial..
12/2/202413:01EDGAR2Form 8-K - Current report
12/2/202412:45BWAN2 to Voluntarily Pause Enrollment in Phase 3 Part of Phase..
30/1/202422:10BWAN2 Therapeutics to Present at Oppenheimer Healthcare Life..
19/1/202400:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/1/202423:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/1/202423:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/1/202401:59EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/1/202400:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/1/202400:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/1/202422:45EDGAR2Form 144 - Report of proposed sale of securities
02/1/202422:36EDGAR2Form 144 - Report of proposed sale of securities
17/11/202300:57EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/11/202322:15EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/11/202322:10EDGAR2Form 8-K - Current report
09/11/202322:05BWAN2 Therapeutics Reports Third Quarter 2023 Financial..
06/11/202313:00BWAN2 Therapeutics to Present at Upcoming Investor Conferences
18/10/202313:00BWAN2 Therapeutics Signs License Agreement with the University..
11/10/202306:01BWAN2 Therapeutics to Present New Data for Epetraborole at..
04/10/202301:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/10/202322:10EDGAR2Form 144 - Report of proposed sale of securities
29/9/202323:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/9/202322:11EDGAR2Form 144 - Report of proposed sale of securities
26/9/202313:00BWAN2 Therapeutics Signs Grant Agreement to Discover Novel,..
15/9/202323:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/9/202314:00EDGAR2Form 8-K - Current report
13/9/202313:00BWAN2 Therapeutics commences Phase 3 Part of Phase 2/3..
08/9/202322:57EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/8/202322:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/8/202322:14EDGAR2Form 144 - Report of proposed sale of securities
16/8/202322:50EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
16/8/202322:47EDGAR2Form 8-K - Current report
16/8/202304:42BWAN2 Therapeutics Announces Pricing of $70.0 Million..
10/8/202322:25EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10/8/202322:18EDGAR2Form 8-K - Current report
10/8/202322:10BWAN2 Therapeutics Reports Second Quarter 2023 Financial..
25/5/202322:10BWAN2 Therapeutics to Present at Jefferies Healthcare..
11/5/202322:10BWAN2 Therapeutics Reports First Quarter 2023 Financial..
Apertura: 2,40 Min: 2,377 Max: 2,49
Chiusura: 2,40

La tua Cronologia

NASDAQ
ANTX
AN2 Therapeutics
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network